Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Tackling consequences of air pollution with drug R&D

Air pollution is a leading cause of death globally, as well as being responsible for new cases of chronic respiratory illnesses, such as asthma and COPD, and lung cancer, it can also aggravate symptoms for existing patients. The spike in cases has induced the global pharma industry to continue its focus on research and development for respiratory illnesses.


Go Top